Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27
Open Access
- 31 July 2006
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 203 (8) , 1875-1881
Abstract
The immune response to bacterial infections must be tightly controlled to guarantee pathogen elimination while preventing tissue damage by uncontrolled inflammation. Here, we demonstrate a key role of interleukin (IL)-27 in regulating this critical balance. IL-27 was rapidly induced during murine experimental peritonitis induced by cecal ligation and puncture (CLP). Furthermore, mice deficient for the EBI3 subunit of IL-27 were resistant to CLP-induced septic peritonitis as compared with wild-type controls, and this effect could be suppressed by injection of recombinant single-chain IL-27. EBI3−/− mice displayed significantly enhanced neutrophil migration and oxidative burst capacity during CLP, resulting in enhanced bacterial clearance and local control of infection. Subsequent studies demonstrated that IL-27 directly suppresses endotoxin-induced production of reactive oxygen intermediates by isolated primary granulocytes and macrophages. Finally, in vivo blockade of IL-27 function using a newly designed soluble IL-27 receptor fusion protein led to significantly increased survival after CLP as compared with control-treated mice. Collectively, these data identify IL-27 as a key negative regulator of innate immune cell function in septic peritonitis. Furthermore, in vivo blockade of IL-27 is a novel potential therapeutic target for treatment of sepsis.Keywords
This publication has 22 references indexed in Scilit:
- Interleukin-27R (WSX-1/T-Cell Cytokine Receptor) Gene-Deficient Mice Display Enhanced Resistance to Leishmania donovani Infection but Develop Severe Liver ImmunopathologyThe American Journal of Pathology, 2006
- ROLE OF C5A IN INFLAMMATORY RESPONSESAnnual Review of Immunology, 2005
- No inhibition of IL-27 signaling by soluble gp130Biochemical and Biophysical Research Communications, 2005
- A Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 Modulates the Inflammatory Response in Murine SepsisJournal of Experimental Medicine, 2004
- The IL-27R (WSX-1) Is Required to Suppress T Cell Hyperactivity during InfectionImmunity, 2003
- TREMs in the immune system and beyondNature Reviews Immunology, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naive CD4+ T CellsImmunity, 2002
- Induction of Direct Antimicrobial Activity Through Mammalian Toll-Like ReceptorsScience, 2001
- Innate ImmunityNew England Journal of Medicine, 2000